Metal contents of liver parenchyma after percutaneous ethanol injection or radiofrequency ablation in patients with hepatocellular carcinoma before and after trientine hydrochloride therapy

Journal of Laboratory and Clinical Medicine

Volumn 143, Issue 6, 2004, Pages 333-339

  Fukuda, Hiroyuki ^a   Ebara, Masaaki ^b   Okabe, Shinichiro ^b   Yoshikawa, Masaharu ^b   Sugiura, Nobuyuki ^b   Saisho, Hiromitsu ^b   Kondo, Fukuo ^b   Yukawa, Masae ^b  

^a CHIBA UNIVERSITY   (Japan)

^b NONE

Author keywords

8 hydroxydeoxyguanosine; 8 OHdG; HCC; HCV; hepatitis C virus; hepatocellular carcinoma; LEC; Long Evans cinnamon; magnetic resonance imaging; MRI; particle induced x ray emission; PIXE

Indexed keywords

ALCOHOL; AMINOTRANSFERASE; COPPER; IRON; METAL; TRIENTINE;

ADULT; AGED; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPPER BLOOD LEVEL; DRUG EFFECT; DRY WEIGHT; FEMALE; HUMAN; HUMAN TISSUE; IRON DEFICIENCY ANEMIA; LIVER; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER PARENCHYMA; MALE; RANDOMIZATION; SIDE EFFECT; TREATMENT OUTCOME; URINALYSIS;

AGED; CARCINOMA, HEPATOCELLULAR; CHELATING AGENTS; COMBINED MODALITY THERAPY; COPPER; ETHANOL; FEMALE; HUMANS; IRON; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIO WAVES; TRIETHYLENETETRAMINE; ZINC;

EID: 3042791027     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lab.2004.02.010     Document Type: Article

References (32)

1. Walshe JM Management of penicillamine nephropathy in Wilson's disease. Lancet. 2:1969;1401-1402
2. Soncin F., Guitton J.D., Cartwright T., Badet J. Interaction of human angiogenin with copper modulates angiogenin binding to endothelial cells. Biochem Biophys Res Commun. 236:1997;604-610
3. Hu G.F. Copper stimulates proliferation of human endothelial cells under culture. J Cell Biochem. 69:1998;326-335
4. Yoshii J., Yoshiji H., Kuriyama S., Ikenaka Y., Noguchi R., Okuda H., et al. The copper-chelating agent trientine suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells. Int J Cancer. 94:2001;768-773
5. Moriguchi M., Nakajima T., Kimura H., Watanabe T., Takashima H., Mitsumoto Y., et al. The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin-8 production. Int J Cancer. 102:2002;445-452
6. Hatano R., Ebara M., Fukuda H., Yoshikawa M., Sugiura N., Kondo F., et al. Accumulation of copper in the liver and hepatic injury in chronic hepatitis C. J Gastroenterol Hepatol. 1:2000;786-791
7. Ebara M., Fukuda H., Hatano R., Yoshikawa M., Sugiura N., Saisho H., et al. Metal contents in the liver of patients with chronic liver disease caused by hepatitis C virus with reference to hepatocellular carcinoma. Oncology. 65:2003;323-330
8. Ebara M., Fukuda H., Hatano R., Saisho H., Nagato Y., Suzuki K., et al. Relationship between copper, zinc and metallothionein in hepatocellular carcinoma and its surrounding liver parenchyma. J Hepatol. 33:2000;415-422
9. Sakurai H., Satoh H., Hatanaka A., Sawada T., Kawano K., Hagino T., et al. Unusual generation of hydroxyl radicals in hepatic copper-metallothionein of LEC (Long-Evans Cinnamon) rats in the presence of hydrogen peroxide. Biochem Biophys Res Commun. 199:1994;313-318
10. Oikawa S., Kurasaki M., Kojima Y., Kawanishi S. Oxidative and nonoxidative mechanisms of site-specific DNA cleavage induced by copper-containing metallothioneins. Biochemistry. 34:1995;8763-8770
11. Cai L., Koropatnick J., Cherian M.G. Metallothionein protects DNA from copper-induced but not iron-induced cleavage in vitro. Chem Biol Interact. 96:1995;143-155
12. Cerutti P.A. Prooxidant states and tumor promotion. Science. 227:1985;375-381
13. Eagon P.K., Teepe A.G., Elm M.S., Tadic S.D., Epley M.J., Beiler B.E., et al. Hepatic hyperplasia and cancer in rats alterations in copper metabolism. Carcinogenesis. 20:1999;1091-1096
14. Jong-Hon K., Togashi Y., Kasai H., Hosokawa M., Takeichi N. Prevention of spontaneous hepatocellular carcinoma in Long-Evans cinnamon rats with hereditary hepatitis by administration of D-penicillamine. Hepatology. 18:1993;614-620
15. Sone H., Maeda M., Wakabayashi K., Takeichi N., Mori M., Sugimura T., et al. Inhibition of hereditary hepatitis and liver tumor development in Long-Evans cinnamon rats by the copper-chelating agent trientine dihydrochloride. Hepatology. 23:1996;764-770
16. Faa G., Nurchi V., Demelia L., Ambu R., Parodo G., Congiu T., et al. Uneven hepatic copper distribution in Wilson's disease. J Hepatol. 22:1995;303-308
17. Steindl P., Ferenci P., Dienes H.P., Grimm G., Pabinger I., Madl C., et al. Wilson's disease in patients presenting with liver disease a diagnostic challenge. Gastroenterology. 113:1997;212-218
18. Khaliquzzaman M., Zaman M.B., Khan A.H. Trace element analysis in biological materials by external beam PIXE. Nucl Instrum Meth. 181:1981;209-215
19. Maenhaut W. Recent advances in nuclear and atomic spectrometric techniques for trace element analysis. A new look at the position of PIXE. Nucl Instrum Meth B. 49:1990;518-532
20. Yukawa M., Sakurai S. Determination of trace elements in biological samples by PIXE using metal film evaporated onto the sample surface as an internal standard. Natl Inst Radiol Sci Ann Rept. 33:1993;70-71
21. Khaliquzzaman M., Zaman M.B., Khan A.H. Trace element analysis in biological materials by external beam PIXE. Nucl Instrum Meth. 181:1981;209-215
22. Walshe J.M. Penicillamine, a new oral therapy for Wilson's disease. Am J Med. 21:1956;487-495
23. Brewer G.J., Terry C.A., Aisen A.M., Hill G.M. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol. 44:1987;490-493
24. Yamaguchi Y. Triethylenetetramine therapy for D-penicillamine-intolerant patients with Wilson's disease preclinical and clinical studies on the safety and clinical efficacy of triethylenetetramine. J Med Soc Toho. 38:1992;756-772
25. Ebara M., Ohto M., Watanabe Y., Kimura K., Saisho H., Tsuchiya Y., et al. Diagnosis of small hepatocellular carcinoma correlation of MR imaging and histologic studies. Radiology. 159:1986;371-377
26. Ebara M., Watanabe S., Kita K., Yoshikawa M., Sugiura N., Ohto M., et al. MR imaging of small hepatocellular carcinoma effect of intratumoral copper content on signal intensity. Radiology. 180:1991;617-621
27. Ebara M., Fukuda H., Kojima Y., Morimoto N., Yoshikawa M., Sugiura N., et al. Small hepatocellular carcinoma relationship of signal intensity to histologic findings and metal content of the tumor and surrounding hepatic parenchyma. Radiology. 210:1999;81-88
28. Tashiro-Itoh T., Ichida T., Matsuda Y., Satoh T., Sugiyama M., Tanaka Y., et al. Metallothionein expression and concentrations of copper and zinc are associated with tumor differentiation in hepatocellular carcinoma. Liver. 17:1997;300-306
29. Sakurai H., Nakajima K., Kamada H., Satoh H., Otaki N., Kimura M., et al. Copper-metallothionein distribution in the liver of Long-Evans cinnamon rats studies on immunohistochemical staining, metal determination, gel filtration and electron spin resonance spectroscopy. Biochem Biophys Res Commun. 192:1993;893-898
30. Thomas J.P., Bachowski G.J., Girotti A.W. Inhibition of cell membrane lipid peroxidatin by cadmium- and zinc-metallothioneins. Biochem Biophys Acta. 884:1986;448-461
31. Shibutani S., Takeshita M., Grollman A.P. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature. 349:1991;431-434
32. Shimoda R., Nagashima M., Sakamoto M., Yamaguchi N., Hirohashi S., Yokota J., et al. Increased formation of oxidative DNA damage, 8- hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res. 54:1994;3171-3172